ESR1 and COVID-19: Based on this updated meta-analysis included 9 RCTs with 718 patients, we found that melatonin may not offer additional benefits to patients with COVID-19 in general, with regards to mortality, recovery of the symptoms, and the reduction in inflammatory markers such as CRP, ESR, and NLR.